PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
Irene Paterniti(University of Messina), Salvatore Cuzzocrea(University of Messina), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Emanuela Mazzon(Centro Neurolesi Bonino Pulejo), Carmen Gil(Instituto de Salud Carlos III), Emanuela Esposito(University of Messina), Daniel I. Pérez(Cedars-Sinai Medical Center), M Garrido Redondo(Instituto de Química Médica), Daniela Impellizzeri(University of Messina)
Cited by 67
Related Papers
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Antiinflammatory Activity of Melatonin in Central Nervous System
|Current Neuropharmacology|2010|406
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348